Heart transplant patients may get new shield against artery disease
NCT ID NCT04770012
First seen May 09, 2026 · Last updated May 14, 2026 · Updated 1 time
Summary
This study tests if starting antiplatelet medication (blood thinners) soon after a heart transplant can prevent a common complication called cardiac allograft vasculopathy (CAV), which narrows the heart's arteries. About 135 adult heart transplant recipients will receive either aspirin, clopidogrel, or a placebo to see if early treatment is feasible and effective. The goal is to keep the new heart healthier longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St.Pauls Hospital
RECRUITINGVancouver, British Columbia, V6Z 1Y6, Canada
Contact
-
Toronto General Hospital UHN
RECRUITINGToronto, Ontario, M5G 2C4, Canada
Contact
-
University of Ottawa Heart Institute
RECRUITINGOttawa, Ontario, K1Y 4W7, Canada
Contact
Conditions
Explore the condition pages connected to this study.